These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14671406)

  • 1. History and future of growth hormone research.
    Kopchick JJ
    Horm Res; 2003; 60 Suppl 3():103-12. PubMed ID: 14671406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.
    Kopchick JJ; Parkinson C; Stevens EC; Trainer PJ
    Endocr Rev; 2002 Oct; 23(5):623-46. PubMed ID: 12372843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the GH/IGF-axis components: lessons from human studies.
    Frystyk J
    Domest Anim Endocrinol; 2012 Aug; 43(2):186-97. PubMed ID: 22153974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone receptor antagonists.
    Kohn DT; Kopchick JJ
    Minerva Endocrinol; 2002 Dec; 27(4):287-98. PubMed ID: 12511851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications.
    Kopchick JJ; List EO; Kelder B; Gosney ES; Berryman DE
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):34-45. PubMed ID: 24035867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of cDNAs for hormones and/or receptors of growth hormone, insulin-like growth factor-I, thyroid hormone, and corticosteroid and the gender-, tissue-, and developmental-specific expression of their mRNA transcripts in fathead minnow (Pimephales promelas).
    Filby AL; Tyler CR
    Gen Comp Endocrinol; 2007 Jan; 150(1):151-63. PubMed ID: 16970945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes.
    Jux C; Leiber K; Hügel U; Blum W; Ohlsson C; Klaus G; Mehls O
    Endocrinology; 1998 Jul; 139(7):3296-305. PubMed ID: 9645706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of growth hormone action and aging: a proteomic perspective.
    Ding J; Sackmann-Sala L; Kopchick JJ
    Proteomics; 2013 Feb; 13(3-4):674-85. PubMed ID: 23019135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
    Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
    Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms and protein structures in growth hormone, growth hormone receptor, ghrelin, insulin-like growth factor 1 and leptin in Mehraban sheep.
    Bahrami A; Behzadi Sh; Miraei-Ashtiani SR; Roh SG; Katoh K
    Gene; 2013 Sep; 527(1):397-404. PubMed ID: 23747407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and glucose metabolism: the model of the GH-receptor antagonists.
    Van der Lely AJ
    Ann Endocrinol (Paris); 2004 Feb; 65(1):81-3. PubMed ID: 15122098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation.
    Kermani H; Goffinet L; Mottet M; Bodart G; Morrhaye G; Dardenne O; Renard C; Overbergh L; Baron F; Beguin Y; Geenen V; Martens HJ
    Neuroimmunomodulation; 2012; 19(3):137-47. PubMed ID: 22261974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and a partial mediator of its biological action, insulin-like growth factor I.
    Pankov YA
    Biochemistry (Mosc); 1999 Jan; 64(1):1-7. PubMed ID: 9986906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: potential impact of increased adiposity, leptin, and insulin with advancing age.
    Berryman DE; Lubbers ER; Magon V; List EO; Kopchick JJ
    J Gerontol A Biol Sci Med Sci; 2014 Feb; 69(2):131-41. PubMed ID: 23695394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone receptor antagonists: discovery and potential uses.
    Kopchick JJ; Okada S
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S103-9. PubMed ID: 11527080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and disorders of the growth hormone receptor (GHR) and GH-GHR signal transduction.
    Rosenbloom AL
    Endocrine; 2000 Apr; 12(2):107-19. PubMed ID: 10905371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of growth hormone (GH) overexpression and GH resistance.
    Bartke A; Chandrashekar V; Bailey B; Zaczek D; Turyn D
    Neuropeptides; 2002; 36(2-3):201-8. PubMed ID: 12359510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and mechanism of action of pegvisomant.
    Kopchick JJ
    Eur J Endocrinol; 2003 Apr; 148 Suppl 2():S21-5. PubMed ID: 12670297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical and novel GH receptor signaling pathways.
    Frank SJ
    Mol Cell Endocrinol; 2020 Dec; 518():110999. PubMed ID: 32835785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.